| Jonathan C Manheim, MD | |
|
1700 N. Wheeling Street, Mailstop 111, Aurora, CO 80045 | |
| (720) 295-6264 | |
| Not Available |
| Full Name | Jonathan C Manheim |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 1700 N. Wheeling Street, Aurora, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730156506 | NPI | - | NPPES |
| 10025742100 | Medicaid | NE | |
| Z3332 | Medicaid | UT | |
| 01354547 | Medicaid | CO | |
| 7725890 | Medicaid | SD | |
| 03316218 | Medicaid | NY | |
| 1730156506 | Medicaid | WY | |
| 200389220A | Medicaid | KS | |
| 30303532 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 35454 (Colorado) | Primary |
| 207R00000X | Internal Medicine | 35454 (Colorado) | Secondary |
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
A new study "Air Pollution Challenges for developing megacities like Delhi" published today in Atmospheric Environment has described how Delhi suffers a toxic blend of geography, growth, poor energy sources and unfavourable weather that perpetuates and propagates its dangerously high levels of air pollution.
AEterna Zentaris Inc. today reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for urology, cetrorelix pamoate. As announced on March 6, 2009, sanofi-aventis U.S. LLC entered into an agreement with AEterna Zentaris for the development, registration and marketing of cetrorelix in BPH for the U.S. market.
The NHS in Coventry and Warwickshire is urging people to choose wisely if they need to use health services over Easter. A&E doctors at University Hospital, Walsgrave have faced spiralling numbers of patients in recent months. And health chiefs are keen to keep the traditional Bank Holiday surge to a minimum as the unit is now a major trauma centre, dealing with more life-threatening illnesses and injuries from much of the Midlands.
Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.
Patients with vitamin D deficiency who received vitamin D supplements had a reduced need for pain relief and lower levels of fatigue in palliative cancer treatment, a randomized and placebo-controlled study by researchers at Karolinska Institutet in Sweden shows.
› Verified 4 days ago
| Entity Name | Healthone Clinic Services - Medical Specialties Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457549461 PECOS PAC ID: 1850480807 Enrollment ID: O20071129000065 |
News Archive
A new study "Air Pollution Challenges for developing megacities like Delhi" published today in Atmospheric Environment has described how Delhi suffers a toxic blend of geography, growth, poor energy sources and unfavourable weather that perpetuates and propagates its dangerously high levels of air pollution.
AEterna Zentaris Inc. today reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for urology, cetrorelix pamoate. As announced on March 6, 2009, sanofi-aventis U.S. LLC entered into an agreement with AEterna Zentaris for the development, registration and marketing of cetrorelix in BPH for the U.S. market.
The NHS in Coventry and Warwickshire is urging people to choose wisely if they need to use health services over Easter. A&E doctors at University Hospital, Walsgrave have faced spiralling numbers of patients in recent months. And health chiefs are keen to keep the traditional Bank Holiday surge to a minimum as the unit is now a major trauma centre, dealing with more life-threatening illnesses and injuries from much of the Midlands.
Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.
Patients with vitamin D deficiency who received vitamin D supplements had a reduced need for pain relief and lower levels of fatigue in palliative cancer treatment, a randomized and placebo-controlled study by researchers at Karolinska Institutet in Sweden shows.
› Verified 4 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
A new study "Air Pollution Challenges for developing megacities like Delhi" published today in Atmospheric Environment has described how Delhi suffers a toxic blend of geography, growth, poor energy sources and unfavourable weather that perpetuates and propagates its dangerously high levels of air pollution.
AEterna Zentaris Inc. today reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for urology, cetrorelix pamoate. As announced on March 6, 2009, sanofi-aventis U.S. LLC entered into an agreement with AEterna Zentaris for the development, registration and marketing of cetrorelix in BPH for the U.S. market.
The NHS in Coventry and Warwickshire is urging people to choose wisely if they need to use health services over Easter. A&E doctors at University Hospital, Walsgrave have faced spiralling numbers of patients in recent months. And health chiefs are keen to keep the traditional Bank Holiday surge to a minimum as the unit is now a major trauma centre, dealing with more life-threatening illnesses and injuries from much of the Midlands.
Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.
Patients with vitamin D deficiency who received vitamin D supplements had a reduced need for pain relief and lower levels of fatigue in palliative cancer treatment, a randomized and placebo-controlled study by researchers at Karolinska Institutet in Sweden shows.
› Verified 4 days ago
| Entity Name | Carepoint Hospital Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205330453 PECOS PAC ID: 4688939903 Enrollment ID: O20180607000495 |
News Archive
A new study "Air Pollution Challenges for developing megacities like Delhi" published today in Atmospheric Environment has described how Delhi suffers a toxic blend of geography, growth, poor energy sources and unfavourable weather that perpetuates and propagates its dangerously high levels of air pollution.
AEterna Zentaris Inc. today reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for urology, cetrorelix pamoate. As announced on March 6, 2009, sanofi-aventis U.S. LLC entered into an agreement with AEterna Zentaris for the development, registration and marketing of cetrorelix in BPH for the U.S. market.
The NHS in Coventry and Warwickshire is urging people to choose wisely if they need to use health services over Easter. A&E doctors at University Hospital, Walsgrave have faced spiralling numbers of patients in recent months. And health chiefs are keen to keep the traditional Bank Holiday surge to a minimum as the unit is now a major trauma centre, dealing with more life-threatening illnesses and injuries from much of the Midlands.
Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.
Patients with vitamin D deficiency who received vitamin D supplements had a reduced need for pain relief and lower levels of fatigue in palliative cancer treatment, a randomized and placebo-controlled study by researchers at Karolinska Institutet in Sweden shows.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan C Manheim, MD 1700 N. Wheeling Street, Mailstop 111, Aurora, CO 80045 Ph: () - | Jonathan C Manheim, MD 1700 N. Wheeling Street, Mailstop 111, Aurora, CO 80045 Ph: (720) 295-6264 |
News Archive
A new study "Air Pollution Challenges for developing megacities like Delhi" published today in Atmospheric Environment has described how Delhi suffers a toxic blend of geography, growth, poor energy sources and unfavourable weather that perpetuates and propagates its dangerously high levels of air pollution.
AEterna Zentaris Inc. today reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for urology, cetrorelix pamoate. As announced on March 6, 2009, sanofi-aventis U.S. LLC entered into an agreement with AEterna Zentaris for the development, registration and marketing of cetrorelix in BPH for the U.S. market.
The NHS in Coventry and Warwickshire is urging people to choose wisely if they need to use health services over Easter. A&E doctors at University Hospital, Walsgrave have faced spiralling numbers of patients in recent months. And health chiefs are keen to keep the traditional Bank Holiday surge to a minimum as the unit is now a major trauma centre, dealing with more life-threatening illnesses and injuries from much of the Midlands.
Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.
Patients with vitamin D deficiency who received vitamin D supplements had a reduced need for pain relief and lower levels of fatigue in palliative cancer treatment, a randomized and placebo-controlled study by researchers at Karolinska Institutet in Sweden shows.
› Verified 4 days ago
Dr. Martin W Rausch, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 2550 S Parker Rd, Aurora, CO 80014 Phone: 303-338-4545 | |
Peter Boulos, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-724-5524 | |
John Watson Iv, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Thuy-quynh Jennifer Le, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 13001 E 17th Pl, Aurora, CO 80045 Phone: 303-724-6595 | |
Hillary L Western, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Dr. Hemali P Patel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12401 E 17th Ave, Suite 450b Mail Stop F-782, Aurora, CO 80045 Phone: 720-848-4289 Fax: 720-848-4293 | |
Madison Hibshman, Hospitalist Medicare: Medicare Enrolled Practice Location: 13001 E 17th Pl, Aurora, CO 80045 Phone: 303-724-1784 |